# Revance Therapeutics, Inc.

Canonical: https://abierto.us/vendors/revance-therapeutics-inc-hy78dqbtllg3

- UEI: HY78DQBTLLG3
- CAGE: 9QP59
- Location: Nashville, TN
- Awards in window: 2 (7 transactions), $0 obligated, February 14, 2024 to December 11, 2025

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 2 awards

## Solicitations won

- Revance Therapeutics, Inc. 65IB 36F79724D0115 Effective 5-15-2024 through 5-14-2024 (36F79724D0115), $225,000. https://abierto.us/opportunities/36f79724d0115

## Largest awards

- 36F79724D0115: $0, Nac Federal Supply Schedule. 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award. https://www.usaspending.gov/award/CONT_IDV_36F79724D0115_3600/
- 36F79724D014E: $0, Nac Federal Supply Schedule. Interim Agreement Under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. https://www.usaspending.gov/award/CONT_IDV_36F79724D014E_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/revance-therapeutics-inc-hy78dqbtllg3.